4//SEC Filing
Jackson Andrew C. 4
Accession 0001641172-25-025445
CIK 0001855485other
Filed
Aug 24, 8:00 PM ET
Accepted
Aug 25, 8:47 PM ET
Size
7.4 KB
Accession
0001641172-25-025445
Insider Transaction Report
Form 4
Jackson Andrew C.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2025-08-21$2.00/sh+2,500$5,000→ 2,500 total - Purchase
Warrant (right to buy)
2025-08-21+2,500→ 2,500 totalExercise: $2.00From: 2025-08-21Exp: 2030-08-21→ Common stock (2,500 underlying)
Footnotes (2)
- [F1]The common stock and warrants were acquired by the reporting person in a public offering conducted by the Issuer that was closed on August 21, 2025.
- [F2]Each common share was purchased with an accompanying warrant for a purchase price of $2.00 per share and accompanying warrant.
Documents
Issuer
Calidi Biotherapeutics, Inc.
CIK 0001855485
Entity typeother
Related Parties
1- filerCIK 0001636738
Filing Metadata
- Form type
- 4
- Filed
- Aug 24, 8:00 PM ET
- Accepted
- Aug 25, 8:47 PM ET
- Size
- 7.4 KB